| Phase 01 trial |
|
Phase 0
|
NCT03498300 |
May 2018 → Apr 2019 |
pertussis, pregnancy disorder |
Mahidol University |
Completed
|
No outcome recorded
|
| Phase 11 trial |
|
Phase 1
|
NCT07492303 |
Apr → Jul 2026 overdue |
diphtheria, pertussis, tetanus |
Changchun BCHT Biotechnology Co. |
Not yet recruiting
|
No outcome recorded
|
| Phase 22 trials |
|
Phase 2
|
NCT03562377 |
Jul 2018 → Sep 2019 |
atopic eczema |
LEO Pharma |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01445743 |
Sep 2011 → Aug 2012 |
pregnancy disorder |
Hospital Universitario Dr. Jose E. Gonzalez |
Completed
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT06494475 |
Dec 2024 → Jun 2025 overdue |
group B streptococcal infection |
Minervax ApS |
Not yet recruiting
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT00518180 |
Jul 2007 → Apr 2008 |
human papilloma virus infection, meningococcal meningitis, pertussis, tetanus |
Novartis Vaccines |
Completed
|
No outcome recorded
|
| Comparator or background therapy1 trial |
|
Phase 2
|
NCT06015308 Background |
Oct 2023 → Oct 2025 |
atopic eczema |
Sanofi |
Completed
|
No outcome recorded
|